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Obesity is an important risk factor for asthma. Obese individuals have decreased circulating adiponectin, an adipose-derived
hormone with anti-inflammatory properties. We hypothesized that transgenic overexpression of adiponectin would attenuate
allergic airways inflammation and mucous hyperplasia in mice. To test this hypothesis, we used mice overexpressing adiponectin
(Adipo Tg). Adipo Tg mice had marked increases in both serum adiponectin and bronchoalveolar lavage (BAL) fluid adiponectin.
Both acute and chronic ovalbumin (OVA) sensitization and challenge protocols were used. In both protocols, OVA-induced
increases in total BAL cells were attenuated in Adipo Tg versus WT mice. In the acute protocol, OVA-induced increases in several
IL-13 dependent genes were attenuated in Adipo Tg versus WT mice, even though IL-13 per se was not affected. With chronic
exposure, though OVA-induced increases in goblet cells numbers per millimeter of basement membrane were greater in Adipo Tg
versus WT mice, mRNA abundance of mucous genes in lungs was not different. Also, adiponectin overexpression did not induce
M2polarizationinalveolarmacrophages.Ourresultsindicatethatadiponectinprotectsagainstallergen-inducedinflammatorycell
recruitment to the airspaces, but not development of goblet cell hyperplasia.
1. Introduction
Obesity is an important risk factor for asthma. Obesity
increases the prevalence, the incidence, and possibly the
severity of asthma, while weight loss improves many asthma
outcomes in the obese [1, 2]. In addition, standard asthma
therapeutic agents are less effective in obese versus lean
asthmatics [3, 4].
Adiponectin is an adipocyte-derived hormone that dec-
lines in obesity [5]. Loss of adiponectin in obesity appears to
have important functional consequences. In animal models,
adiponectin deficiency exacerbates several obesity-related
conditions, including insulin resistance and atherosclerosis
[6, 7]. In obese human subjects, serum adiponectin levels
are inversely correlated with the risk of type 2 diabetes,
atherosclerosis, and hypertension [8–10]. Some, but not all,
epidemiological studies suggest that obesity-related declines
inadiponectinmayalsocontributetoobesity-relatedasthma.
Forexample,inacohortofpremenopausalwomen,theriskof
a s t h m aw a sg r e a t e s ti ns u b j e c t si nt h el o w e s tt e r t i l eo fs e r u m
adiponectin [11]. Similarly, in C57BL/6 mice, adiponectin
deficiency worsens airway eosinophilia and macrophage
recruitment induced by chronic allergen challenge [12]. In
addition,wehaveshownthatinleanBalb/Cmice,continuous
infusion of adiponectin via mini-Alzet pumps suppresses
acute allergen-induced airway hyperresponsiveness, airway
inflammation, and Th2 cytokine production [13]. Simi-
larly, Ionescu et al. reported a reduction in allergic airway
inflammationinallergenchallengedmicetreatedintranasally
with recombinant adiponectin [14]. These data suggest that2 Journal of Allergy
manipulatingadiponectinlevelsmighthavebeneficialeffects
for asthma. However, none of these studies examined goblet
cell metaplasia, a common feature of asthma (reviewed in
[15] )a n do fa n i m a lm o d e l so fa s t h m a .A d i p o n e c t i nr e c e p t o r s
are expressed on airway epithelial cells [16], and we have
previously reported that compared to wildtype (WT) mice,
acute allergen sensitization and challenge results in reduced
mucous cell staining in the airways of T-cadherin deficient
mice, which have increased circulating adiponectin [17].
These data suggest that adiponectin may have the capacity to
impact goblet cell metaplasia.
Some of the observed beneficial effects of adiponectin in
the airways [13, 14] may be related to its anti-inflammatory
effects, particularly its effects on macrophages, although
adiponectin also has proinflammatory effects [18–20].
Adiponectin decreases the ability of LPS or Toll-like
receptor activation to elicit TNF𝗼 and IL-6 production from
macrophages [21–24] and reduces eotaxin expression in
bone marrow derived macrophages stimulated with TNF𝗼
and IL-4 [12]. Adiponectin also inhibits the transformation
of macrophages to foam cells [25], which may explain the
antiatherosclerotic effects of adiponectin. Cultured alveolar
macrophages from adiponectin deficient mice demonstrate
increased production of TNF𝗼,b o t hi n n a t e l ya n du p o n
stimulation with LPS [26]. Adiponectin has also been
shown to promote an anti-inflammatory, M2 phenotype in
macrophages of various origins [27–29]. Such effects may
be magnified in the setting of allergic lung disease which is
associated with induction of Th2 cytokines that also promote
M2 polarization.
The purpose of this study was to determine whether
transgenicoverexpressionofadiponectincouldaffectallergic
airways responses, including goblet cell hyperplasia. To do
so, we used mice overexpressing adiponectin from a chicken
beta-actin promoter/cytomegalovirus enhancer. We have
previously reported that these mice have marked increases in
serum adiponectin [30]. Two allergen sensitization and chal-
lenge protocols were employed. The first, an acute challenge
protocol,wassimilartothatusedinapreviousstudyinwhich
weexaminedtheeffectsofadiponectinadministeredbymini-
Alzet pumps [13]a n dw a su s e da sap r o o fo fc o n c e p tt h a t
adiponectinoverexpressedinthismannerwouldbeeffective.
The second protocol, a chronic challenge protocol, results
in allergic airways inflammation and goblet cell metaplasia,
that is dependent on mast cells [31], as is allergic asthma
in humans, whereas the acute protocol requires T cells but
n o tm a s tc e l l s[ 32]. The transgenic expression of adiponectin
allowed increased levels of this adipokine to be present
throughout the extended challenge period needed for this
protocol.
2. Materials and Methods
2.1. Animals. This study was approved by the Harvard Med-
ical Area Standing Committee on Animals. Transgenic mice
overexpressing adiponectin (Adipo Tg) driven by a chicken
beta-actin promoter with a cytomegalovirus enhancer and
backcrossed onto a C57BL/6J background were generated
as previously described [33]. Adipo Tg mice (which were ±
for the transgene) were mated with WT littermates, and
the Adipo Tg and littermate WT offspring of these matings
were used in experiments described below. Primers used for
genotyping were 5
򸀠-GCT TAT ATG TAT CGC TCA GCG
TTC AG-3
򸀠 and 5
򸀠-CTT GTC GTC GTC GTC CTT GTA
GTC-3
򸀠.U s i n gt h e s ep r i m e r s ,a4 38b pp r o d u c tw a so b s e rv e d
in the Adipo Tg but not the WT mice.
2.2. Allergen Sensitization and Challenge
2.2.1. Acute Protocol. F o u r - w e e k - o l dm a l em i c ew e r es e n s i -
tized to chicken egg albumin (ovalbumin (OVA), Grade V,
Sigma-AldrichCo.,St.Louis,MO)onday1byintraperitoneal
injection of 20𝜇g of OVA and adjuvant, 2mg of aluminum
hydroxide (Al(OH)3;J .T .B a k e r ,P h i l l i p s b u r g ,N J )d i s p e r s e d
in 0.2mL of PBS. Mice were given a second injection of
identical reagents on day 14.O ndays 28 through 30,m i c e
were challenged for 30min with an aerosol of either PBS
containing 1% OVA or PBS alone, as previously described
[34]. Mice were studied 24h after the last OVA challenge.
2.2.2. Chronic Protocol. F o u r - w e e k - o l dm a l em i c ew e r es e n -
sitizedtoOVAondays1,4,and7 byintraperitonealinjection
of 50𝜇g OVA dispersed in 0.1mL of PBS without alum.
Beginning on day 12,m i c ew e r ei n t r a n a s a l l yc h a l l e n g e do n c e
a week for 4 weeks with either sterile PBS or OVA (20𝜇gi n
30𝜇LPBS)asdescribedbyothers[31].Micewerestudied24h
after the last OVA challenge.
2.3. Bronchoalveolar Lavage (BAL). Mice were euthanized
with an overdose of sodium pentobarbital, blood was drawn
by cardiac puncture, and serum stored at −20
∘Cf o rs u b -
sequent measurement of total serum adiponectin and IgE
by ELISA. BAL was performed and the BAL cells and
differentials counted as described previously [13, 34]. BAL
supernatant was stored at −80
∘C and subsequently analyzed
by ELISA for adiponectin, eotaxin, and IL-13 (R&D Systems
Inc.). OVA specific IgE in serum was analyzed by ELISA
(Cayman Chemical).
2.4. Histology and Morphometry. For mice in the chronic
OVA protocol, twenty-four hours after the last exposure to
O V Ao rP B S ,m i c ew e r ee u t h a n i z e da n dl u n g sp r o c e s s e df o r
histology as previously described [35]. Briefly, the lungs were
inflated in situ at 20cm of water with 4% paraformaldehyde
and then removed en bloc. The left lung was cut, embedded
in paraffin, and sections stained with periodic acid Schiff
(PAS) to assess mucous-containing goblet cells. Sections
were viewed using an upright light microscope equipped
with SPOT CCD camera and Image Pro software (Olympus
Canada,Mississauga,ON).Airwayswereselectedforanalysis
that exhibited a maximum diameter: minimum diameter
r a t i ot h a tw a sl e s st h a n≤2 to avoid artifacts from airways cut
obliquely. Basement membrane (BM) length was measured
f o ra l la i r w a y s .F o rm e a s u r e m e n to fg o b l e tc e l la b u n d a n c e ,a
band-shaped region of interest extending from the BM to the
edge of the epithelium was drawn, using a maximum length
thatavoidedsectioningartifacts.UsingImagePro(Olympus)Journal of Allergy 3
Table 1: Primers used for qRT-PCR.
Gene Forward primer (5
򸀠 →3
򸀠) Reverse primer (5
򸀠 →3
򸀠)
Alox15 ATGGTGCTGAAGCGGTCTAC ATCCGCTTCAAACAGAGTGC
Cxcl9 TCCTCTTGGGCATCATCTTC TGAGGGATTTGTAGTGGATCG
Il13 CAGCATGGTATGGAGTGTGG AGGCCATGCAATATCCTCTG
Il17a CTCCAGAAGGCCCTCAGACTA AGCTTTCCCTCCGCATTGACACAG
Itln1 AGAACCTGGACACCAACAGG GTGCGCAGGAAATAGAGACC
Clec10a CAGTGGAGAAGAGGGAGCAG AGCCGTTGTTCTTGAGGTTG
Muc5ac ACCCAGAGGGTCAGTGTGAG TTGGGATAGCATCCTTCCAG
Retnla TCGTGGAGAATAAGGTCAAGG GGAGGCCCATCTGTTCATAG
Chi3l3 GAAGGAGCCACTGAGGTCTG TTGTTGTCCTTGAGCCACTG
Clca3 GATTCCCGAGAGCTGGAAG TGTTCGGTGTAGGGCTCATC
Agr2 GCGATCAGCTCATCTGGACT GCTTGACTGTGTGGGCATT
18S ribosomal RNA GTAACCCGTTGAACCCCATT CCATCCAATCGGTAGTAGCG
software, thresholds for detecting goblet cells were set to
enable discrimination between individual mucous-positive
cells, so that the numbers of cells per mm of BM could
be determined. Images of at least 3 different airways were
captured for each animal. Other sections were stained with
hematoxylinandeosintodeterminetheinflammationindex,
a product of the severity and prevalence of inflammation,
as described by Hamada et al. [36]. Severity was assigned
an u m e r i c a lv a l u eb a s e du p o nt h en u m b e ro fi n fl a m m a t o r y
cell infiltrate layers surrounding the airways or blood vessels
( 0 ,n oc e l l s ;1 ,≤3 cell layers; 2, 4–9 cell layers; 3, 10 cell
layers).Prevalenceofinflammationwasassignedanumerical
value according to the percentage of airways or blood vessels
in each section encompassed by inflammatory cells (0,
none; 1, ≤25%; 2, 25–50%; 3, >50%). Medium to large sized
airways were analyzed, and in each mouse, a minimum of 8
airways were examined. For both goblet cell hyperplasia and
inflammation, a mean value for each mouse was computed
a n du s e df o rs t a t i s t i c a la n a l y s e s .
2.5. RNA Extraction and Real-Time PCR. Lungs were har-
vested, frozen at −80
∘C, and subsequently homogenized for
RNA extraction with RNeasy (Qiagen). Total RNA (1𝜇g)
was reverse transcribed using random hexamer primers and
Superscript III (Invitrogen). Quantitative mRNA expression
for each gene was performed using real-time PCR and SYBR
Green(AppliedBiosystems).PrimersaredescribedinTable 1.
Values were calculated based on the ΔΔCT method, and 18S
was used to control for total mRNA. For each set of primers,
melting curve analysis yielded a single peak consistent with
one PCR product.
2.6. Statistical Analysis of Results. Data were analyzed by
factorial ANOVA (BAL and serum moieties, histological
analyses, and lung mRNA expression) using STATISTICA
software (StatSoft, Tulsa, OK). BAL cells were log trans-
formedinordertoconformtoanormaldistribution.Fisher’s
LSDtestwasusedforposthoccomparisons.A𝑃value<0.05
was considered statistically significant.
3. Results
3.1. Acute Allergen Challenge Protocol
3.1.1. Adiponectin Expression and Body Weight. Compared to
WTlittermates,AdipoTgmicehadmarkedincreasesinboth
serum and BAL fluid adiponectin (Figure 1). Adiponectin
levels in the serum were not significantly altered by exposure
to OVA, though there was a trend towards increased BAL
adiponectin in OVA versus PBS treated mice (𝑃 = 0.076).
Neither adiponectin genotype nor OVA had any effect on
bodymass.Bodymassaveraged26.9±0.5,26.7±0.6,26.5±1.0,
and27.0±0.7ginWTmicechallengedwithPBSorOV A,and
A d i p oT gm i c ec h a l l e n g e dw i t hP B So rO V Ar e s p e c t i v e l y .
3.1.2. Pulmonary Inflammation. Factorial ANOVA indicated
a significant effect of OVA versus PBS exposure on total BAL
cells. Follow-up analysis indicated that the effect occurred in
the WT mice. Total BAL cells increased from 2.7 ± 0.5 to
9 . 1±4 . 2×1 0
4 cells/mL in WT mice (𝑃 < 0.05), whereas
therewasnosignificanteffectofOVAversusPBSexposurein
Adipo Tg mice (2.1±0.2versus3.9±0.5×10
4 cells/mL).OVA
inducedasignificantincreaseinneutrophils,eosinophils,and
lymphocytes (Figure 2(a))i nW Tm i c e .C o m p a r e dt oW T
mice, OVA-induced increases in lymphocytes were signif-
icantly reduced in adiponectin transgenic mice. A similar
trend was observed for neutrophils and eosinophils but did
not reach statistical significance. There was no effect of either
OVA exposure or genotype on BAL epithelial cells (data not
shown). In contrast, circulating leukocytes were not different
between wildtype and adiponectin transgenic mice, except
for a reduction in circulating neutrophils in WT OVA versus
PBS treated mice (Figure 2(b)). These observations suggest
that genotype-related reductions in infiltration of airspaces
by inflammatory cells were not the result of a deficiency in
the availability of these cells in the blood.
Compared to PBS, OVA challenge increased BAL IL-13
(Figure 2(c)). There was no significant genotype-related dif-
ference, although there was a trend for reduced BAL IL-134 Journal of Allergy
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Figure 1: Serum (a) and bronchoalveolar lavage (BAL) fluid (b) adiponectin concentrations in wildtype (WT) and adiponectin transgenic
(Adipo Tg) mice sensitized to ovalbumin (OVA) and challenged with aerosols of OVA or PBS every day for 3 days. Data shown are mean ±
SEM of 5–7 mice per group.
#𝑃 < 0.05 versus WT mice with the same exposure.
in Adipo Tg mice. OVA induced a significant increase in
BAL eotaxin in WT but not Adipo Tg mice (Figure 2(d)).
Similarly, OVA exposure increased OVA-specific serum IgE
(Figure 2(e)) in WT mice, but not in Adipo Tg mice.
3.1.3. Pulmonary Gene Expression. Real-time PCR was used
to measure changes in mRNA abundance of genes known to
bestronglyinducedinthelungsbyOVAchallengeinthispro-
tocol [37–44]. In WT mice, inhalation of OVA significantly
increased pulmonary expression of Retnla, Itln1, Alox15,
Muc5ac, Cxcl9, Clca3, Agr2,a n dIl17a mRNA (Figure 3).
OVA-induced Retnla, Itln1, Alox15, Clca3, and Agr2 mRNA
abundance was significantly lower in Adipo Tg than WT
mice.AsimilartrendwasobservedforMuc5acandCxcl9,but
the effect did not reach statistical significance. Il17a mRNA
abundance was not different in Adipo Tg and WT mice.
3.2. Chronic Allergen Challenge Protocol
3.2.1.PulmonaryInflammation. ComparedtoPBSchallenge,
repeated intranasal OVA challenge caused significant
increases in BAL neutrophils, eosinophils, and lymphocytes
(Figure 4(a)), although eosinophils were lower than those
induced with the acute challenge protocol (Figure 2(a)).
Importantly, OVA-induced increases in BAL neutrophils
and eosinophils were significantly attenuated in Adipo
Tg versus WT mice. There was no effect of either OVA
challenge or adiponectin genotype on circulating leukocytes
(Figure 4(b)). Compared to PBS, OVA challenge increased
BAL IL-13 in WT mice (Figure 4(c)). BAL IL-13 was
significantly reduced in Adipo Tg versus WT OVA exposed
mice. BAL eotaxin was also significantly lower in Adipo Tg
versus WT OVA exposed mice (Figure 4(d)). Compared
t oP B S ,O V Ac h a l l e n g ec a u s e das i g n i fi c a n ti n c r e a s ei n
serum OVA-specific IgE, but there was no effect of genotype
(Figure 4(e)).
OVAchallengeresultedinaccumulationofinflammatory
cells around airways (Figure 5), but there was no significant
difference in the extent of these cell infiltrates in WT versus
Adipo Tg mice (Figure 6(a)). We also examined goblet cell
hyperplasia in these mice. Compared to PBS, chronic OVA
i.n. challenge significantly increased the number of goblet
cells per mm of BM in the airways in both WT and Adipo
Tg mice (Figures 5 and 6(b)). However, there was a small
but significant increase in goblet cell hyperplasia in the OVA
challenged Adipo Tg versus WT mice.
3.2.2. Gene Expression. Similar to the results obtained with
the acute OVA exposure protocol, chronic intranasal instil-
lation of OVA significantly increased pulmonary expression
of Retnla, Itln1, Alox15, Clca3, Agr2, Muc5ac,a n dCxcl9
(Figure 7), although the magnitude of these changes was
substantially reduced compared to the acute OVA protocol
(Figure 3). However, in contrast to the acute OVA exposure
protocol, OVA-induced increases in the expression of these
geneswerenotsignificantlyaffectedbytransgenicstatus.Il17a
mRNAexpressionwasnotinducedbyi.n.OVA(Figure 7(h)).
S i n c eo t h e r sh a v er e p o r t e de ff e c t so fa d i p o n e c t i no n
macrophage phenotype [27, 29], we also measured addi-
tional markers of M2 phenotype in the lungs of theseJournal of Allergy 5
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Figure 2: Leukocytes in BAL fluid (a) and blood (b) and BAL IL-13 (c), BAL eotaxin (d), and serum OVA-specific IgE (e) of wildtype (WT)
and adiponectin transgenic (Adipo Tg) mice sensitized with ovalbumin (OVA) and exposed to aerosols of OVA or PBS. Data shown are
mean ± SEM of 5-6 PBS and 9-10 OVA treated mice per group except for OVA-specific IgE (𝑛=5 -6 for PBS and 12-13 for OVA).
∗𝑃 < 0.05
versusPBSchallengedmiceofthesamegenotype;
#𝑃 < 0.05versusWTmicewiththesameexposure.MAC:macrophages;NEU:neutrophils;
EOS: eosinophils; LYM: lymphocytes; MON: mononuclear cells.
mice. Compared to PBS, chronic OVA challenge caused
as i g n i fi c a n ti n c r e a s ei nb o t hChi3l3 and Clec10a (Mgl1), but
there was no genotype-related difference in the induction of
thesegenesbyOVA(Figures8(a)and8(b)).Wealsoevaluated
expression of M2 associated genes in alveolar macrophages
isolated from na¨ ıve WT and Adipo Tg mice (Figure 8(c)).
Chi3l3, Clec10a, and Retnla mRNA levels were not different
i nm a c r o p h a g e si s o l a t e df r o mW Ta n dA d i p oT gm i c e .
4. Discussion
Our data indicate that adiponectin overexpression results
in a significant reduction in inflammatory cell recruitment
to the airspaces (Figure 2) and in the induction of genes
known to drive airway inflammation (Figure 3)a ft e ra c u t e
OVA challenge. A similar reduction in BAL inflammatory
c e l l sa sw e l la sr e d u c t i o n si nB A Le o t a x i na n dI L - 1 3w i t h
adiponectinoverexpressionwasobserved(Figure 4)whenwe
used a chronic OVA challenge protocol in which inflamma-
tion is dependent on mast cells [31], a feature relevant to
human allergic asthma. Importantly, others have previously
reported that adiponectin deficiency results in increased
allergic airways inflammation in this chronic challenge pro-
tocol, likely as a result of effects on chemokine expression,
especiallyeotaxin[12].Sincemucoushypersecretionislargely
refractory to current therapies, we also used the chronic
protocol to determine whether adiponectin overexpression
m i g h ta l s ob ee ff e c t i v ea g a i n s tt h i sa s p e c to ft h ea l l e r g i c
airways phenotype. Interestingly, despite having no effect on
Muc5ac mRNA abundance (Figure 7), we observed modestly
highergobletcellhyperplasiainmicewithexcessadiponectin
(Figure 6).
Adiponectin overexpression caused a reduction in the
number of cells emigrating into the airspaces after acute6 Journal of Allergy
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Figure3:PulmonarymRNAexpressionofRetnla(a),Itln1 (b),Alox15 (c),Clca3(d),Agr2(e),Muc5ac (f),Cxcl9(g),andIl17a(h)inwildtype
(WT) and adiponectin transgenic (Adipo Tg) mice sensitized with ovalbumin (OVA) and exposed to aerosols of OVA or PBS every day for 3
days. Data shown are the means ± SEM of 5-6 mice/group. Data are normalized relative to 18S expression.
∗𝑃 < 0.05 versus PBS challenged
mice of the same genotype;
#𝑃 < 0.05 versus WT mice with the same challenge.
OVA challenge, consistent with previous observations using
exogenous adiponectin administration and a similar allergen
challenge model [13]. We also observed significant changes
in BAL eotaxin in WT but not Adipo Tg mice after acute
OVA challenge. Eotaxin has been shown to contribute to
eosinophil recruitment following allergen challenge in mice
[45]. OVA specific IgE was also increased by OVA exposure
in WT but not Adipo Tg mice (Figure 2(e)). These data
confirm results of previous studies that examined the impact
of exogenous adiponectin administration [13, 14], albeit in
a different strain of mice (C57BL/6 versus Balb/c). Thus,
our findings provided proof of concept that the transgenic
mice would be a useful model to use for a chronic allergen
challenge protocol in which elevated serum adiponectin
needed to be sustained for an extended period (see below).
Data from the acute challenge protocol extend results
of previous studies by providing effects on expression of
inflammatory genes relevant to allergic airways disease.
For example, we observed a significant reduction in OVA-
induced expression of Retnla, Itln1, Clca3, Agr2, and Alox15
mRNA in Adipo Tg versus WT mice (Figure 3). Intelectin
[37]a n dAlox15 [42, 46] have each been shown to contribute
to allergic airways inflammation in mice. Thus, our data
suggest that adiponectin-dependent reductions in BAL cells
may have been secondary to changes in the expression
of these genes. In contrast to the effects of adiponectin
overexpression on Retnla, Itln1, Alox15, Clca3, and Agr2
mRNA (Figures 3(a)–3(e)) ,w ed i dn o to b s e r v ea n ye ff e c t so f
adiponectin on induction of either Cxcl9 or Il17a following
acute OVA challenge (Figures 3(g) and 3(h)). Induction of
Retnla, Itln1, Alox15, Clca3, and Agr2 by acute OVA challenge
is dependent upon IL-13, whereas induction of Cxcl9 and
Il17a is not [38, 42, 44, 46, 47]. Nevertheless, we did not
observe any significant change in BAL IL-13 in Adipo Tg
versus WT mice nor was there any difference in lung IL-13
mRNAabundance(datanotshown).Takentogether,thedata
suggestthatadiponectinmaymediateitseffectsonexpression
of Retnla, Itln1, Alox15, Clca3, and Agr2 downstream of IL-13
rather than directly impacting IL-13 expression.
We also examined the effects of adiponectin overexpres-
sion using a chronic OVA challenge protocol using weekly
intranasal administration of OVA. We chose to examine
this protocol because both inflammation and goblet cell
hyperplasiarequiremastcellswiththisprotocol[31],increas-
ing the relevance to human asthma. In contrast, with the
acuteOVAchallengeprotocol,theseoutcomesaredependent
upon T cells, but not mast cells [32]. Our data indicated
that BAL inflammatory cells, IL-13, and eotaxin are reducedJournal of Allergy 7
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Figure 4: Leukocytes in BAL fluid (a) and blood (b), and BAL IL-13 (c), BAL eotaxin (d), and serum OVA-specific IgE (e) in wildtype (WT)
and adiponectin transgenic (Adipo Tg) mice sensitized with ovalbumin (OVA) and challenged i.n. with OVA or PBS every week for 4 weeks.
Data shown are mean ± SEM of 5–10 mice per group.
∗𝑃 < 0.05 versus PBS challenged mice of the same genotype;
#𝑃 < 0.05 versus WT
mice with the same challenge. MAC: macrophages; NEU: neutrophils; EOS: eosinophils; LYM: lymphocytes; MON: mononuclear cells.
in Adipo Tg versus WT mice (Figure 4). These data are
consistent with other reports showing that adiponectin defi-
ciencyincreasesallergicairwaysinflammationwiththissame
challenge protocol [12]. Though our findings with respect
to inflammation in chronic OVA-exposed mice (Figure 4)
are similar to those from the acute OVA exposure mice
(Figure 2),thereweresomedifferences.Whereasadiponectin
overexpression reduced both inflammatory cell number and
IL-13inBALinchronicOVA-exposedanimals(Figure 4),we
observednodifferenceinlunginflammatorygeneexpression
(Figures 7 and 8). This contrasts with the marked reduction
in gene expression induced by adiponectin overexpression
with the acute OVA protocol (Figure 3). Consistent with the
lack of effect on pulmonary gene expression in the chronic
protocol,adiponectinoverexpressionhadnoeffectoninflam-
mation within the lung tissue: semi-quantitative analysis of
airway inflammation from histological sections indicated no
genotype-relatedeffect (Figure 6). Taken together, the results
suggest that in the chronic OVA model, adiponectin may
act to prevent inflammatory/immune cell transit across the
airway epithelium.
We sought to determine whether transgenic expression
of adiponectin might be effective in reducing the goblet cell
metaplasia associated with allergic airways disease. Goblet
cell metaplasia was induced in this chronic OVA challenge
model(Figures5and6),andtherewasalsosignificantinduc-
tion of genes involved in mucous cell metaplasia (Muc5ac,
Agr2, and Clca3)( Figure 7). Nevertheless, we observed a
modest but significant increase in goblet cells in Adipo Tg
mice versus WT mice (Figures 5 and 6). To our knowl-
edge, this is the first study examining effects of adiponectin
on goblet cell metaplasia in the lungs, although others
have reported significant reductions in other aspects of the
remodeling process (pulmonary vascular and airway smooth
muscle cell proliferation) in mice with elevated adiponectin
[14, 48].8 Journal of Allergy
PBS OVA
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PBS OVA
Adiponectin transgenic
(a) (b) (c) (d)
(e) (f) (g) (h)
Figure 5: Histological sections of airways of wildtype (WT) and adiponectin transgenic (Adipo Tg) mice sensitized with ovalbumin (OVA)
without alum and challenged intranasally with OVA or PBS every week for 4 weeks (chronic). Light micrographs showing H&E (panels
(a)–(d)) or PAS (panels (e)–(h)) staining. Arrowheads in (a)–(d) indicate regions of inflammatory cell accumulation. Arrows in (e)–(h)
indicate regions of “purple” staining that were recognized by Image Pro software (Olympus) during quantification of goblet cell abundance
(see text). The bars in panels (a) and (e) = 10𝜇m and correspond to all images in the upper and lower row, respectively. PAS staining for
mucous-containing goblet cells ((e)–(h)) is from medium sized peripheral airways.
We were somewhat surprised to find that adiponectin
overexpression augmented goblet cell hyperplasia, especially
since IL-13, which is widely considered to drive this pheno-
t y p e ,w a sr e d u c e di nt h eA d i p oT gm i c e( Figure 4(c)). It is
conceivablethattheapparentincreaseingobletcellsinAdipo
Tgmicewastheresultoflessreleaseofmucusintotheairways
and consequent increased retention of mucus within the
cells themselves. However, the observation that expression of
Agr2 and Clca3 also tended to increase in Adipo Tg versus
WT mice (Figure 7)s u g g e s t so t h e r w i s e .O fn o t e ,Agr2 is an
endoplasmic reticulum protein required for production of
mucous glycoproteins like Muc5ac [49], while Clca3 (gob-
5) is required for OVA-induced goblet cell metaplasia and
airspace inflammation in mice [50]. The increased goblet
cell numbers and the trend towards increased Agr2 and
Clca3 mRNA abundance in the Adipo Tg versus WT mice
is consistent with the results of other investigators who have
examined the impact of adiponectin on goblet cell hyperpla-
siainotherorgans[51,52].Forexample,Saxenaetal.reported
that adiponectin increases the differentiation of intestinal
epithelial cells towards goblet cells [52]. Similarly, Li et al.
reportedthatexogenousadministrationofadiponectininthe
formofeyedropsincreasedconjunctivalgobletcelldensityin
a mouse model of experimental dry eye [51].
In the Adipo Tg mice, adiponectin concentrations were
extremely high both in the BAL fluid and the serum. It is
possible that proinflammatory effects of adiponectin [18–20]
impacted goblet cell numbers due to these sustained high
concentrations. Contrary to this contention, we did observe
reductionsinbothAgr2 andClca3mRNAinAdipoTgversus
WT mice upon acute OVA challenge. Others have used the
chicken beta-actin promoter, cytomegalovirus enhancer thatJournal of Allergy 9
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Figure 6: Quantitation of inflammatory cell accumulation around airways (a) and goblet cell metaplasia (b). Data shown are the means ±
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drove adiponectin expression in these mice to drive EGFP
[53].Inthelungsoftheresulting“green”mice,EGFPismostly
observed in the airway epithelium. Hence, it is conceivable
that the enhanced goblet cell numbers are a consequence
of coexpression of a transgene within these cells, although
mRNA expression of epithelial genes (i.e., Itln1, Retnla, Agr2,
Clca3, and Muc5ac) was not affected (Figure 7). Further
investigation will be required to identify the cellular and
molecularmechanismsatplay.Nonetheless,ourobservations
suggest that the molecular mechanisms controlling goblet
cell hyperplasia in response to sustained chronic allergen
challenge may be regulated by mechanisms that are differentJournal of Allergy 11
from those that regulate immune cell accumulation within
the airways.
Expression of Retnla, Itln1, Alox15, Agr2, and Clca3 was
not reduced in Adipo Tg versus WT mice after chronic OVA
challenge (Figure 7), whereas adiponectin overexpression
caused a marked reduction in these same genes following
a c u t eO V Ac h a l l e n g e( Figure 3). The differences in these
observations may relate to differences in the mast cell/T
cell dependence of the two models, as discussed above. For
example, the cell targeted by adiponectin in acute protocol
may be T cells themselves. It is also important to note that
t h em a g n i t u d eo ft h ei n fl a m m a t i o ni n d u c e db yc h r o n i cO V A
challenge was substantially less than that induced by acute
challenge (BAL eosinophilia in Figures 2 and 4, and gene
expression in Figures 3 and 7). It is conceivable that with the
moresubduedinflammationinthechronicprotocol,endoge-
nous levels of adiponectin are sufficient to provide maximal
inhibition of gene expression, and increasing adiponectin
further has no effect. It is also possible that differences in
the magnitude of inflammation induced in the two models
contribute directly to differences in gene expression, since
RNA was evaluated in whole lung: differences in lung gene
expression may reflect the different cell populations in the
lungs under the different conditions and the different gene
expression profiles of these cells.
O u rd a t ad on o ts u p p o r tar o l ef o ra d i p o n e c t i ni na l t e r -
native activation of lung macrophages. Firstly, we observed
no difference in the expression of genes classically associated
withM2statusinalveolarmacrophagesharvestedfromna¨ ıve
A d i p oT gv e r s u sW Tm i c e( Figure 8(c)), despite evidence
that these macrophages normally exist in a microenviron-
ment replete with excess adiponectin (Figure 1(b)). Secondly,
adiponectin overexpression either had no effect on (Figures
7 and 8) or significantly reduced (Figure 3)O V A - i n d u c e d
increases in the expression of Retnla, Chi3l3,a n dClec10a.I n
contrast, in macrophages from other sources, including peri-
toneal macrophages, adipose tissue macrophages, Kupffer
cells, bone marrow or monocyte-derived macrophages, and
macrophagecelllines,adiponectinaugmentstheinductionof
these M2 genes either on its own or in conjunction with Th2
cytokines[27–29].EffectsofadiponectinonexpressionofM2
genes in lung macrophages has not previously been exam-
ined, although there is evidence that adiponectin deficiency
increases M1 type activation of lung macrophages, as indi-
cated by increased MHC class 2 expression and augmented
TNF𝗼 production [26, 27]. However, adiponectin can also
have proinflammatory effects on lung macrophages, since
macrophages from adiponectin deficient mice produce less
TNF𝗼 in response to cigarette smoke extract than wildtype
mice [54].
5. Conclusions
In conclusion, transgenic overexpression of adiponectin in
m i c ep r o t e c t e da g a i n s tt h ed e v e l o p m e n to fa l l e r g i ca i r w a y s
inflammation and expression of IL-13 dependent genes
after acute OVA challenge. Airspace inflammation was also
reducedbyadiponectinoverexpressionafterchronicOVA.In
contrast, inflammatory gene expression was not impacted by
adiponectin overexpression, and goblet cell hyperplasia was
increased. The data indicate that the ability of adiponectin
supplementation to ameliorate allergic airways disease is
dependent on the nature of the model employed. From a
clinical perspective, our data suggest that increasing circulat-
ing adiponectin in obese individuals or agonists that target
adiponectin receptors would be expected to decrease allergic
airway inflammation but would not be beneficial in reducing
the mucous metaplasia characteristic of allergic asthma.
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